Pharmacoeconomics in the new millennium a pharmaceutical industry perspective

PharmacoEconomics

Volumn 13, Issue 2, 1998, Pages 175-180

  Thwaites, Rob ^a   Townsend, Raymond J ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b RJ Townsend Co Pharmacoeconomic R   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; HEALTH CARE DELIVERY; MARKET; PHARMACOECONOMICS; PRIORITY JOURNAL; SHORT SURVEY;

DELIVERY OF HEALTH CARE; DRUG INDUSTRY; ECONOMICS, PHARMACEUTICAL; HUMANS; RESEARCH;

EID: 0031940852     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199813020-00002     Document Type: Short Survey

References (9)

1. Commonwealth Department of Human Services and Health. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Commonwealth of Australia, 1995
2. Canadian Co-ordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceutical. 2nd ed. Ottawa: CCOHTA, 1997
3. Garattini L, Grilli R, Scopelliti D, et al. A proposal for Italian guidelines in pharmacoeconomics. Pharmacoeconomics 1995; 7 (1): 1-6
4. Alban A, Gyldmark M, Pedersen AV, et al. The Danish approach to standards for economic evaluation methodologies. Pharmacoeconomics 1997; 12 (6): 627-36
5. Quality of life and clinical trials [editorial]. Lancet 1945; 346: 1-2
6. Clemens K, Townsend R, Luscumbe F, et al. Methodological and conduct principles for pharmacoeconomic research. Pharmacoeconomics 1995; 8 (2): 169-74
7. UK Department of Health and the Association of the British Pharmaceutical Industry. Pharmaceutical industry and Department of Health guidelines for the economic analysis of medicines. London: UK Department of Health, 1964
8. Drummond MF. The future of pharmacoeconomics: quality of life and pharmacoeconomics in clinical trials. 2nd ed. Spilker B. editor. Philadelphia: Lippincott-Raven Publishers, 1996
9. Walley T, Barton S, Cooke J, et al. Economic evaluations of drug therapy: attitudes of primary care advisers in Great Britain. Health Policy 1997; 41: 61-72